BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2009
View Archived Issues
[123I]MNI-420 shows promise for imaging A2A receptors in the brain
Read More
Novel antimalarials reported by the Instituto Nacional de Pesquisas da Amazonia
Read More
University of Sydney claims new series of translocator protein ligands
Read More
Institut Pasteur, CNRS, INSERM design novel anti-HIV inhibitors
Read More
Hong Kong University of Science and Technology describes novel NMDA antagonists
Read More
High Point Pharmaceuticals discloses inhibitors of TNF-alpha production and PDE4
Read More
Immunoadhesins for human IL-10, a novel approach in cancer immunotherapy
Read More
Kyowa Hakko Kirin reports results from first quarter 2009
Read More
Clinuvel receives European approval to initiate phase III trial of afamelanotide in EPP
Read More
Nuevolution and Novartis sign drug discovery collaboration involving Chemetics
Read More
Piramal Life Sciences completes ascending-dose phase I studies of P-1736 in diabetes
Read More
FDA accepts Pozen's NDA for Vimovo in OA, RA and AS
Read More
Lumavita is granted marketing authorization in Switzerland for pentamycin for vaginitis
Read More
CRTH2 receptor antagonists in early development at Argenta Discovery
Read More
FDA grants orphan drug designation to Quinazoline-495 for spinal muscular atrophy
Read More
FDA Advisory Committee to discuss Genzyme's sNDA for Clolar in adult AML
Read More
Effect of rosuvastatin on atrial fibrillation in heart failure patients unclear
Read More
PLATO study: reduced cardiovascular events with ticagrelor versus clopidogrel in ACS
Read More
Schering-Plough completes recruitment into phase I trial of SCH-900795 for influenza
Read More
Delcath Systems enrolls 90% of patients into phase III clinical trial of PHP in metastatic melanoma
Read More
Otamixaban superior to unfractionated heparin in non-S-T segment ACS patients
Read More
NovaBiotics completes phase I of phase I/IIa clinical trial of Novexatin for fungal nail infection
Read More
Studies analyze the benefit of ivabradine in patients with coronary artery disease
Read More
Pfizer investigating 5-HT2C agonists for serotonin-related disorders
Read More
Antisoma completes enrollment into phase III trial of ASA-404 in NSCLC
Read More
FDA accepts for review Johnson & Johnson's complete response letter for ceftobiprole NDA
Read More
Shire submits NDA to FDA for velaglucerase alfa and reports results from phase III trials
Read More